- View More...
-
- Author
- s.e. jorgensen(4)
- shao y(2)
- aria f.(1)
- zoran m.(1)
- alizadeh t(1)
- anderson rf(1)
- aprahamian m(1)
- arne?(1)
- babur m(1)
- bacher jd(1)
-
- Journal
- cellular physiology ...(1)
- experimental neurolo...(1)
- journal of plastic, ...(1)
- planta medica(1)
- schweizerische zeits...(1)
- urologic oncology: s...(1)
Now showing items 17 - 18 of 18
-
Journal Citation List for OxyLiteTM and OxyFloTM
Epel B Redler Tormyshev V Halpern Hj Nesbitt H Browne Gulmez O Donovan Km Byrne Nm Worthington J Mckeown Sr P J Mckenna Connor O Boult Jp Jamin Y Jk Babur M Finegan Kg Williams Kj Little Ra Jackson A Parker Gj Reynolds Ar Waterton Jc Robinson Sp Li F Jørgensen Jt James A Forman Hansen Ae Kjaer A Frank J Gündel Siegfried Drescher Thews O Mäder K Gremonprez F Descamps Izmer A Vanhove C Vanhaecke F De Wever Ceelen W Hueting R Muschel Rj Dilworth Jr Bluff Je Reynolds S Metcalf Alizadeh T Kazan Sm Bucur A Wholey Eg Bibby Ba Williams L Paley Mn Tozer Gm Levy Eb Johnson Cg Gordon Jacobs Woods Dl Sharma Kv Bacher Jd Lewis Al Dreher Mr Fleming In Manavaki R West C Harris Al Domarkas J Lord Baldry C Gilbert Fj Guillaume Collet Nathalie Lamerant-Fayel Tertil M El Hafny-Rahbi Stepniewski J Guichard A Foucault-Collet Klimkiewicz K Petoud Matejuk A Grillon C Jozkowicz A Dulak J Kieda C Laurens E Raykov Z Grekova Sp Gaëtan Bour Lehn Jm Giese Na Nicolau C Aprahamian M Bailey Km Cornnell Hh Ibrahim-Hashim A Wojtkowiak Jw Hart Cp Zhang X Leos R Martinez Gv Gillies Rj Tran Lb Jordan B Grégoire Vand Gallez Weiss A Van Beijnum Jr Bonvin D Jichlinski P Dyson Pj Griffioen Aw Nowak-Sliwinska Li Cx Wong Bl Ling Cc Ma Yy Shao Y Geng W Qi X Lau Sh Kwok Sy Wei N Tzang Fc Ng Kt Liu Xb Man K Sun Cj Li C Lv Hb Zhao C Yu Jm Wang Gh Luo Yx Li Y Xiao M Yin J Lang Jy Skrzypek K Florczyk Weglarczyk K Was Henri Collet Guichard A Gil T Kuzdzal J Pichon C Hueting R Kersemans Gouverneur V Jordan Bf Magat J Colliez Ozel E Fruytier Ac Marchand V Mignion L Gallez B Ting-Ting Huang Civelek Ac Zheng H Ng Ck Duan X Li J Postel Gc Shen B Li Xf Jonathan D Pagan Przybyla B Jamshidi-Parsian A Gupta K Griffin Rj Ming L Camac Sn Mitchell Ca Ward C Waugh Dj Magat J Schakman O Marbaix E Coudyzer P Lemoine Galant C Nisolle M Courtoy Pj Henriet P Benedicte Collet Lamerant-Fayel N Kotlinowski J Fylaktakidou Kc Vidal A Auzeloux P Miot-Noirault E Beloeil Skrzypek K Golda S Ciesla Weglarczyk K Collet Muchova L Vitek L Loboda A Mia Deschepper Manassero M Oudina K Paquet Monfoulet Le Grégoire V Thrall De Maccarini P Stauffer P Macfall Joshua Hauck Matthew Snyder Case B Linder Lan L Emmanouil Fokas Yoshimura M Prevo R Higgins G Hackl W Maira Sm Bernhard Ej Mckenna Wg Byrne N Camac S Mitchell C Waugh D Mckeown S Ellingsen C Ovrebø Km Galappathi K Mathiesen B Rofstad Ek Myers Al Orr Ws Denbo Jw Ng Cy Jian-Wei Zhou Spence Y Wu J Davidoff Am Meng F Evans Jw Bhupathi D Banica Lan L Lorente Duan Jx Cai X Mowday Am Guise Cp Maroz A Anderson Rf Patterson Av Stachelek Gc Glazer Pm Matteucci Md Carreau A Serganova I Rizwan A Ni X Thakur Sb Vider J Russell J Blasberg R Koutcher Ja
(2015). Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure; increases intraperitoneal chemotherapy drug penetration; and impedes tumor growth in a mouse colorectal carcinomatosis model. (2015). A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo. (2015). Measurement of the acute metabolic response to hypoxia in rat tumours in vivo using magnetic resonance spectroscopy and hyperpolarised pyruvate. (2014). Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth. AM and Ackermann U (2014). Radiolabelling and evaluation of a novel sulfoxide as a PET imaging agent for tumor hypoxia. (2014). Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. (2014). Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy. (2014). Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization. Plasma jet-induced tissue oxygenation: potentialities for new therapeutic strategies. (2014). A novel oxygen carrier "YQ23" suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells. (2014). Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model. (2014). Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1. (2014). Hypoxia-regulated over expression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth. (2014). Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model. (2013). Application of MOBILE (mapping of oxygen by imaging lipids relaxation enhancement) to study variations in tumor oxygenation. Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy. (2013). (18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings. (2013). Blood outgrowth endothelial cells increase tumor growth rates and modify tumor physiology: relevance for therapeutic targeting. (2013). Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response. (2013). Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model. (2013). Hypoxia is not required for human endometrial breakdown or repair in a xenograft model of menstruation. Lehn JM and Nicolau C (2013). Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment. and Dulak J (2013). Interplay between heme oxygenase-1 …Download Collect -
NORADRENERGIC FACILITATION OF MOTOR NEURONS LOCALIZATION OF ADRENERGIC RECEPTORS IN NEURONS AND NONNEURONAL CELLS IN THE TRIGEMINAL MOTOR NUCLEUS
SHAO Y SUTIN J
Both .alpha.- and .beta.-adrenergic receptors (ARs) are involved in the facilitation of the monosynaptic jaw-closing reflex in the trigeminal motor nucleus (MoV) caused by norepinephrine (NE). The amplitude of muscle spindle afferent-evoked EPSPs in masseter motor neurons is 65% greater when noradrenergic axons to the motor nucleus are concomitantly activated and seems to be due to a presynaptic mechanism (Vornov, J.J., and J. Sutin. 1986. J. Neurosci. 6: 30-37). To determine the subtypes of ARs located on motor neurons and other cells, the cytotoxic lectin Ricin communis was injected into the masseter nerve of the trigeminal motor root to eliminate motor neurons in the masseter subnucleus of MoV. Autoradiography following incubation of tissue sections in the .alpha.1 ligand 125IBE 2254 (125I-HEAT) or the nonselective .beta. ligand [125I]iodocyanopindolol (125ICYP) showed a decrease in .alpha.1-AR binding related to the motor neuron degeneration and an increase in .beta.-AR binding related to the motor neuron degeneration and an increase in .beta.-AR binding associated with the glial reaction. To determine the extent to which glial proliferation was responsible for the increase in .beta.-ARs, cytosine arabinofuranoside (AraC) was administered to inhibit mitosis. Following AraC treatment, the total number of glial cells in the ricin-treated MoV was similar to that in normal MoV. Both .beta.-AR density and GFAP immunoreactivity remain increased, but to a lesser degree than following the ricin treatment alone. AraC also partially prevented the increase of immunolabeled or histochemically visualized microglia and capillary endothelial cells. The coincidence of the increases in .beta.-AR binding and GFAP in a region devoid of neurons argues that reactive astrocytes and other nonneuronal cells express .beta.-ARs in vivo. To determine whether the increase in astroglial .beta.-ARs was due to an up-regulation resulting from transsynaptic degeneration of NE terminals, NE content was measured in MoV tissue punches, and NE terminals were visualized by immunocytochemical labeling of dopamine-.beta.-hydroxylase. NE content and NE terminal density remained unchanged following ricin-induced motor neuron degeneration.Download Collect